Traders Sell Shares of AbbVie (ABBV) on Strength (ABBV)

Lloyd Doyle
May 16, 2018

The company's stock declined 6.31% with the market as Sns Financial Group Llc sold 52,018 shares. The hedge fund run by Andrew Feldstein held 113,074 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $10.94 million, up from 39,554 at the end of the previous reported quarter. The stock has a market capitalization of $165.32 billion, a PE ratio of 18.91, a P/E/G ratio of 0.98 and a beta of 1.59. The stock increased 1.64% or $1.71 during the last trading session, reaching $105.89. Rothschild Investment Corp IL raised its holdings in shares of AbbVie by 2.5% in the 3rd quarter.

Credit Suisse Group set a $109.00 price target on AbbVie (NYSE:ABBV) in a research note published on Sunday. It has outperformed by 27.65% the S&P500.

Paccar Inc (NASDAQ:PCAR) had a decrease of 15.54% in short interest. Arrowstreet Capital Limited Partnership reported 2.08 million shares. Its down 14.9% from 398,100 shares previously. The SI to Paccar Inc's float is 2.78%.

The stock decreased 0.17% or $0.02 during the last trading session, reaching $12.09. About 821,758 shares traded.

Nuveen New York Amt-free Municipal Income Fund (NRK) investors sentiment increased to 1.57 in Q4 2017. Its down 0.05, from 0.85 in 2017Q3. The shares were sold at an average price of $117.85, for a total value of $2,946,250.00.

Andrew Feldstein increased its stake in Abbvie Inc (ABBV) by 185.87% based on its latest 2017Q4 regulatory filing with the SEC.

AbbVie (NYSE:ABBV) last released its earnings results on Thursday, April 26th. Strategic Svcs Incorporated holds 5,122 shares or 0.08% of its portfolio. First Light Asset Ltd Liability reported 0.11% stake. New England Research & Management Inc. now owns 9,308 shares of the company's stock worth $827,000 after purchasing an additional 4,700 shares during the period. 3,647 are owned by Harvest Capital. Oppenheimer Com holds 0.56% or 224,047 shares. To measure price-variation, we found ABBV's volatility during a week at 2.12% and during a month it has been found around 2.29%. Moreover, St Germain D J Inc has 0.06% invested in AbbVie Inc. Wagner Bowman Mngmt holds 15,426 shares.

Since December 14, 2017, it had 0 insider purchases, and 11 insider sales for $47.70 million activity. (NYSE:ABBV) was sold by GONZALEZ RICHARD A on Wednesday, February 28.

In other news, EVP Carlos Alban sold 83,574 shares of the business's stock in a transaction that occurred on Thursday, March 1st. Capital International Investors now owns 7,854,929 shares of the company's stock worth $697,989,000 after buying an additional 4,550,954 shares in the last quarter. On Thursday, December 14 the insider Schumacher Laura J sold $14.07M. $8.31 million worth of AbbVie Inc. Also, VP Robert A. Michael sold 992 shares of AbbVie stock in a transaction that occurred on Tuesday, February 20th. Finally, Parsec Financial Management Inc. grew its holdings in AbbVie by 265.3% during the third quarter. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. (NYSE:ABBV) were released by: and their article: "AbbVie: Can Mylan Pull Off A Humira Biosimilar?" published on May 01, 2018 as well as's news article titled: "Kiniksa Pharmaceuticals files for initial public offering" with publication date: April 27, 2018. (NYSE:ABBV). $976,084 worth of AbbVie Inc. During the same period in the previous year, the firm earned $1.20 earnings per share. equities analysts predict that AbbVie will post 7.57 earnings per share for the current fiscal year. The rating was downgraded by Citigroup on Monday, November 28 to "Neutral". Mackenzie Corporation, Ontario - Canada-based fund reported 761,072 shares.

AbbVie stock opened at $92.49 on Friday. On Monday, May 29 the stock rating was maintained by Jefferies with "Buy". (NYSE:ABBV) rating on Monday, July 17. The stock has "Mkt Perform" rating by Leerink Swann on Tuesday, October 18.

Macromill, Inc. provides marketing research services worldwide. The Truck segment offers trucks that are used for the over-the-road and off-highway hauling of commercial and consumer goods. It dropped, as 42 investors sold ABBV shares while 695 reduced holdings. 214.70 million shares or 0.34% more from 213.97 million shares in 2017Q3 were reported. They expect $1.97 earnings per share, up 38.73 % or $0.55 from last year's $1.42 per share. Horan Cap Advsrs Ltd Liability has invested 5.56% in AbbVie Inc. Paragon Cap Limited reported 10,250 shares. Axa invested 0.01% in PACCAR Inc (NASDAQ:PCAR). American Economic Planning Group Inc Adv accumulated 2,514 shares or 0.09% of the stock. Virginia Retirement Et Al accumulated 0.02% or 25,400 shares. Tealwood Asset Inc has 103,319 shares for 3.7% of their portfolio. Virtue Capital Management LLC acquired a new stake in AbbVie in the 4th quarter valued at approximately $139,000. Raymond James Tru Na owns 5,736 shares. Ameritas Prtnrs Inc reported 14,050 shares or 0.05% of all its holdings. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company's stock. Therefore 67% are positive.

Analysts await AbbVie Inc. The rating was maintained by SunTrust on Friday, February 9 with "Buy". The company presently has an average rating of "Buy" and a consensus price target of $116.38. Finally, Barclays reduced their price target on AbbVie from $120.00 to $102.00 and set an "equal weight" rating for the company in a report on Thursday, April 5th. The firm earned "Hold" rating on Wednesday, June 7 by BMO Capital Markets. The company was maintained on Wednesday, April 25 by Robert W. Baird.

Other reports by Iphone Fresh

Discuss This Article